Metraipolis › archive › dc_609a35f7e6e2
Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors — Europe PMC PMID:41347170
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41347170
- DOI
- 10.3389/fphar.2025.1696229
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T10:21:07.713Z
- SHA-256 of the archived text
b79518d0b5abf9bf82e431fdd55b799dda0df631174229f41974a8f6de03c747- Stable URL of this page
https://metraipolis.com/documento/dc_609a35f7e6e2
How to cite
Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors — Europe PMC PMID:41347170 — Europe PMC (en), https://europepmc.org/article/MED/41347170 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_609a35f7e6e2 (Metraipolis archive dc_609a35f7e6e2, sha256 b79518d0b5abf9bf82e431fdd55b799dda0df631174229f41974a8f6de03c747)
BibTeX
@misc{dc609a35f7e6e2,
title = {Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors — Europe PMC PMID:41347170},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41347170},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_609a35f7e6e2; sha256 b79518d0b5abf9bf82e431fdd55b799dda0df631174229f41974a8f6de03c747},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41347170. Agents can read the archived copy with the MCP tool read_document.